Icaritin, a novel plant-derived osteoinductive agent, enhances the osteogenic differentiation of human bone marrow- and human adipose tissue-derived mesenchymal stem cells
Authors:
Open Access
- 24 February 2017
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 39 (4) , 984-992
Abstract
For the treatment of diseases affecting bones using bone regenerative medicine, there is an urgent need to develop safe, inexpensive drugs that can strongly induce bone formation. In the present study, we systematically investigated the effects of icaritin, a metabolic product of icariin, on the osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells (hBMSCs) and human adipose tissue‑derived stem cells (hADSCs) in vitro. After treatment with icaritin at concentrations of 10‑8-10‑5 M, hBMSCs and hADSCs were examined for alkaline phosphatase activity, osteocalcin (OC) secretion, matrix mineralization and expression levels of bone‑related mRNA and proteins. Data showed that icaritin at concentrations 10‑7-10‑5 M significantly increased alkaline phosphatase activity, OC secretion at different time points, and calcium deposition at day 21. In addition, icaritin upregulated the mRNA expression of genes for bone morphogenetic proteins (BMP‑2, ‑4 and ‑7), bone transcription factors (Runx2 and Dlx5) and bone matrix proteins (ALP, OC and Col‑1). Moreover, icaritin increased the protein levels of BMPs, Runx2 and OC, as detected by western blot analysis. These findings suggest that icaritin enhances the osteogenic differentiation of hBMSCS and hADSCs. Icaritin exerts its potent osteogenic effect possibly by directly stimulating the production of BMPs. Although the osteogenic activity of icaritin in vitro was inferior to that of rhBMP‑2, icaritin displayed better results than icariin. Moreover, the low cost, simple extraction procedure, and an abundance of icaritin make it appealing as a bone regenerative medicine.Keywords
This publication has 46 references indexed in Scilit:
- A nano-micro alternating multilayer scaffold loading with rBMSCs and BMP-2 for bone tissue engineeringColloids and Surfaces B: Biointerfaces, 2015
- The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorptionBiomaterials, 2014
- Dual Delivery of BMP-2 and bFGF from a New Nano-Composite Scaffold, Loaded with Vascular Stents for Large-Size Mandibular Defect RegenerationInternational Journal of Molecular Sciences, 2013
- A Novel Low-Molecular-Weight Compound Enhances Ectopic Bone Formation and Fracture RepairJournal of Bone and Joint Surgery, 2013
- Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect modelJournal of Tissue Engineering and Regenerative Medicine, 2012
- The Dose-Effect of Icariin on the Proliferation and Osteogenic Differentiation of Human Bone Mesenchymal Stem CellsMolecules, 2011
- Development and optimization of a cell‐based assay for the selection of synthetic compounds that potentiate bone morphogenetic protein‐2 activityCell Biochemistry and Function, 2009
- Bone morphogenetic proteins 5 and 6 stimulate osteoclast generationJournal of Biomedical Materials Research Part A, 2005
- The Osteoinductive Activity of Bone Morphogenetic Protein (BMP) Purified by Repeated Extracts of Bovine BoneGrowth Factors, 2004
- Gene Therapy Approaches for Bone RegenerationCells Tissues Organs, 2004